Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- CREAD 2
A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer’s Disease (AD)
Neurodegenerative Disorder Alzheimer's Disease (AD)
Study results
LPS BN29553 CREAD2 Final Results March 2022 English
(PDF, 0.3 MB)
LPS BN29553 CREAD2 Final Results March 2022 Arabic
(PDF, 0.8 MB)
LPS BN29553 CREAD2 Final Results March 2022 Chinese Hong kong
(PDF, 0.9 MB)
LPS BN29553 CREAD2 Final Results March 2022 Chinese Simplified PRC
(PDF, 0.9 MB)
LPS BN29553 CREAD2 Final Results March 2022 Chinese Traditional Taiwan
(PDF, 1.0 MB)
LPS BN29553 CREAD2 Final Results March 2022 Danish
(PDF, 0.6 MB)
LPS BN29553 CREAD2 Final Results March 2022 Estonian
(PDF, 0.4 MB)
LPS BN29553 CREAD2 Final Results March 2022 French
(PDF, 0.5 MB)
LPS BN29553 CREAD2 Final Results March 2022 German
(PDF, 0.5 MB)
LPS BN29553 CREAD2 Final Results March 2022 Italian
(PDF, 0.5 MB)
LPS BN29553 CREAD2 Final Results March 2022 Japanese
(PDF, 0.7 MB)
LPS BN29553 CREAD2 Final Results March 2022 Korean
(PDF, 0.8 MB)
LPS BN29553 CREAD2 Final Results March 2022 Norwegian
(PDF, 0.4 MB)
LPS BN29553 CREAD2 Final Results March 2022 Polish
(PDF, 0.8 MB)
LPS BN29553 CREAD2 Final Results March 2022 Portuguese
(PDF, 0.4 MB)
LPS BN29553 CREAD2 Final Results March 2022 Portuguese Brazil
(PDF, 0.6 MB)
LPS BN29553 CREAD2 Final Results March 2022 Russian
(PDF, 0.8 MB)
LPS BN29553 CREAD2 Final Results March 2022 Serbian
(PDF, 0.7 MB)
LPS BN29553 CREAD2 Final Results March 2022 Spanish
(PDF, 0.6 MB)
LPS BN29553 CREAD2 Final Results March 2022 Spanish Argentina
(PDF, 0.6 MB)
LPS BN29553 CREAD2 Final Results March 2022 Spanish Mexico
(PDF, 0.3 MB)
LPS BN29553 CREAD2 Final Results March 2022 Spanish Peru
(PDF, 0.6 MB)
LPS BN29553 CREAD2 Final Results March 2022 Swahili
(PDF, 0.6 MB)
LPS BN29553 CREAD2 Final Results March 2022 Swedish
(PDF, 0.6 MB)
LPS BN29553 CREAD2 Final Results March 2022 Turkish
(PDF, 0.4 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com